Related by context. Frequent words. (Click for all words.) 56 irbesartan 56 interferon beta 1a 54 noninferiority 54 glatiramer acetate 52 P = .# 52 EBRT 52 STELARA 52 placebo p = 52 Natalizumab 51 DOXIL 51 CI #.#-#.# [002] 50 chemoradiotherapy 50 relapsing MS 50 XELOX 50 Secondary endpoints included 50 HSCT 49 ADAS cog 49 natalizumab 49 pg mL 49 median PFS 49 p = #.# [004] 49 patients evaluable 49 % CI #.#-#.# [007] 49 complete cytogenetic 49 univariate analysis 48 PCa 48 ACR# response 48 CI -#.# 48 evaluable 48 IPSS 47 fingolimod 47 etoposide 47 interferon beta 47 statistically significant p = 47 pg ml 47 LVEF 47 TNF α 47 placebo p 47 SWOG 47 RRMS 47 nonsignificant 47 exemestane 47 % CI #.#-#.# [006] 47 biochemical recurrence 47 verapamil 47 GSK# [001] 46 confidence interval #.#-#.# 46 ACR# [002] 46 serum concentrations 46 RECIST criteria 46 confidence interval CI 46 talabostat 45 PANSS 45 Thrombolysis 45 ISOCOUNTRY3 45 p = #.# [002] 45 PsA 45 MIs 45 liver transplant recipients 45 exacerbations 45 relapsing remitting multiple sclerosis 45 EORTC 45 DTIC 45 sd = 45 myocardial infarction stroke 45 multivariate analyzes 45 MDD 45 DAS# [002] 45 RTOG 45 relapsing remitting MS 44 p = 44 statistically significant p 44 beta interferon 44 Secondary endpoints include 44 % CI #.#-#.# [002] 44 n = 44 relapsing remitting 44 ACTH 43 Hydrochloride 43 stable angina 43 Alemtuzumab 43 JMR Sunnex 43 CGRP 43 systemic embolism 43 thromboembolism 43 Extavia 42 ± SD 42 Disease Activity 42 mg ml 42 ≥ 42 prospective randomized controlled 42 Unified Parkinson Disease 41 CI = 41 1mg 41 ALLHAT 41 neutralizing antibody 41 ECOG 41 NSABP 41 Copaxone 41 randomized Phase III 41 Multicenter